Biocept, Inc.
Biocept, Inc. (BIOC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bioc · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Biocept, Inc. (BIOC) measures how much investors pay for each dollar of the company's trailing earnings. BIOC's current PE ratio of N/A is calculated by dividing its stock price of $0.43 by its TTM earnings per share of -$56.78.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2011 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Biocept, Inc.You BIOC | $0M | N/A | — | -$56.78 |
 Atlantic International Corp. ATLN | $66M | N/A | — | -$1.08 |
 GBS Inc. GBS | $0M | N/A | — | -$2.00 |
 Leafly Holdings, Inc. LFLY | $115M | N/A | — | -$2.30 |
 Ontrak, Inc. OTRK | $2M | N/A | — | -$5.49 |
 BiomX Inc. PHGE | $1M | N/A | — | -$0.52 |
 Phio Pharmaceuticals Corp. PHIO | $13M | N/A | — | -$1.45 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-56.78 | — | |
2021-12-31 FY2021 | — | $-5.73 | — | |
2020-12-31 FY2020 | — | $-43.16 | — | |
2019-12-31 FY2019 | — | $-357.54 | — | |
2018-12-31 FY2018 | — | $-2634.46 | — | |
2017-12-31 FY2017 | — | $-7074.87 | — | |
2016-12-31 FY2016 | — | $-17292.60 | — | |
2015-12-31 FY2015 | — | $-23282.32 | — | |
2014-12-31 FY2014 | — | $-96744.18 | — | |
2013-12-31 FY2013 | — | $-55288.52 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Biocept, Inc. (BIOC) measures how much investors pay for each dollar of the company's trailing earnings. BIOC's current PE ratio of N/A is calculated by dividing its stock price of $0.43 by its TTM earnings per share of -$56.78.
Frequently asked questions
BIOC pe ratio · 6 questionsBIOC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.43 and TTM EPS of -$56.78. Data sourced from Financial Modeling Prep via BIOC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biocept, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09